Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Times Interest Earned (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 13 years of Times Interest Earned data on record, last reported at $4.03 in Q3 2025.

  • For Q3 2025, Times Interest Earned fell 52.69% year-over-year to $4.03; the TTM value through Dec 2025 reached $2.07, down 69.49%, while the annual FY2024 figure was $6.77, 6.67% down from the prior year.
  • Times Interest Earned reached $4.03 in Q3 2025 per AMPH's latest filing, down from $5.93 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $144.36 in Q4 2021 and bottomed at $4.03 in Q3 2025.
  • Average Times Interest Earned over 5 years is $44.01, with a median of $25.64 recorded in 2023.
  • Peak YoY movement for Times Interest Earned: skyrocketed 341.24% in 2021, then plummeted 93.36% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at $144.36 in 2021, then tumbled by 50.37% to $71.65 in 2022, then tumbled by 92.03% to $5.71 in 2023, then rose by 23.08% to $7.03 in 2024, then plummeted by 42.65% to $4.03 in 2025.
  • Per Business Quant database, its latest 3 readings for Times Interest Earned were $4.03 in Q3 2025, $5.93 in Q1 2025, and $7.03 in Q4 2024.